71 Pa. Stat. § 1691.2

Current through Pa Acts 2024-53, 2024-56 through 2024-92
Section 1691.2 - Definitions

The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:

"Department." The Department of Drug and Alcohol Programs of the Commonwealth.

" Medication- relateddeath." A death where a medication approved by the United States Food and Drug Administration for the treatment of opioid use disorder was:

(1) a primary or secondary cause of death; or
(2) may have been a contributing factor.

" Medication- related incident." A situation where a medication approved by the United States Food and Drug Administration for the treatment of opioid use disorder may be a contributing factor which:

(1) does not involve a fatality; and
(2) involves:
(i) a serious injury; or
(ii) unreasonable risk of death or serious injury.

"Opioid-assisted treatment program." A program licensed and approved by the Department of Drug and Alcohol Programs for chronic opiate drug users that administers or dispenses agents under a narcotic treatment physician's order, either for detoxification purposes or for maintenance.

"Opioid use disorder." A problematic pattern of opioid use leading to clinically significant impairment or distress.

"Secretary." The Secretary of Drug and Alcohol Programs of the Commonwealth.

"Team." The Medication Death and Incident Review Team established under section 3.

71 P.S. § 1691.2

Amended by P.L. TBD 2020 No. 126, § 1, eff. 2/23/2021.
Added by P.L. 1198 2012 No. 148, § 2, eff. 1/22/2013.